Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Northland Bioscience
United Statesnorthlandbioscience.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Northland Bioscience is a US-based research firm specializing in the development of new line therapies and first-in-class drugs. The company focuses on enhancing drug efficacy, bioavailability, and targeted delivery using proprietary technologies. No specific clinical results or late-stage programs are publicly disclosed.
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
Cooperation with corporate partnersCooperation with healthcare organizationsCooperation with governing agencies
Beyond the preview
Go deeper on Northland Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Northland Bioscience.